GlassScriptPhysician profile
Andrew T Blackburne
NPI 1437412582
$6,801.20
in general payments reported to CMS, 2019-2025
41 companies · $1,694 in 2025
The $1,694 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $71.10 · 2021: $691 · 2022: $1,007 · 2023: $1,698 · 2024: $1,342 · 2025: $1,694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,700 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,699.83 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $867.29 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $767.53 | 2019-2025 | Spaceoar Vue System - 10ml, Lumenis Pulse 120h, Ams 700 |
| Astellas Pharma US INC | $518.84 | 2019-2024 | Myrbetriq |
| Antares Pharma, INC. | $460.95 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Janssen Biotech, INC. | $444.44 | 2022-2025 | Erleada, Rybrevant, Carvykti |
| Myriad Genetic Laboratories, INC. | $442.90 | 2021-2025 | Prolaris |
| Urogen Pharma, INC. | $435.95 | 2022-2025 | Jelmyto |
| Procept Biorobotics Corporation | $350.89 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Accord Healthcare, INC. | $325.38 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $187.56 | 2024-2025 | Adstiladrin |
| Olympus America INC. | $179.87 | 2023-2025 | Itind System |
| Abbvie INC. | $176.12 | 2022-2025 | Botox |
| Dendreon Pharmaceuticals LLC | $132.58 | 2024-2025 | Provenge |
| Teleflex LLC | $132.02 | 2021-2024 | Urolift |
| Novartis Pharmaceuticals Corporation | $123.21 | 2022-2025 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Blackburne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.